68Ga/177Lu-NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use

被引：0
|
作者：
Dalm, Simone [2 ]
Bakker, Ingrid [2 ]
de Blois, Erik [2 ]
Doeswijk, Gabriela [2 ]
Konijnenberg, Mark [2 ]
Orlandi, Francesca [1 ]
Barbato, Donato [1 ]
Tedesco, Mattia [1 ]
Maina, Theodosia [3 ]
Nock, Berthold [3 ]
de Jong, Marion [2 ]
机构：
[1] Adv Accelerator Applicat, Colleretto Giacosa, Italy
[2] Erasmus MC, Rotterdam, Netherlands
[3] NCSR Demokritos, INRASTES, Mol Radiopharm, Athens, Greece
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
331
引用
收藏
页数：2
相关论文
共 50 条
  • [1] 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology
    Dalm, Simone U.
    Bakker, Ingrid L.
    de Blois, Erik
    Doeswijk, Gabriela N.
    Konijnenberg, Mark W.
    Orlandi, Francesca
    Barbato, Donato
    Tedesco, Mattia
    Maina, Theodosia
    Nock, Berthold A.
    de Jong, Marion
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) : 293 - 299
  • [2] 68Ga/177Lu-NeoBOMB1, A Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology (vol 58, pg 293, 2017)
    Dalm
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (07) : 1164 - 1164
  • [3] 177Lu-NeoBOMB1 for GRPR-mediated cancer treatment: the effect of peptide mass on efficacy and safety
    Dalm, Simone
    de Blois, Erik
    Haeck, Joost
    Doeswijk, Gabriela
    Orlandi, Francesca
    Barbato, Donato
    Tedesco, Mattia
    Konijnenberg, Mark
    De Jong, Marion
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [4] Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with 68Ga and 177Lu as Potential Theranostic Agents
    Salvanou, Evangelia-Alexandra
    Kolokithas-Ntoukas, Argiris
    Liolios, Christos
    Xanthopoulos, Stavros
    Paravatou-Petsotas, Maria
    Tsoukalas, Charalampos
    Avgoustakis, Konstantinos
    Bouziotis, Penelope
    [J]. NANOMATERIALS, 2022, 12 (14)
  • [5] Theranostic perspectives of [67Ga/111In/177Lu]NeoBOMB1 in prostate cancer - First evidence for clinical translation with [68Ga]NeoBOMB1 and PET/CT
    Nock, B. A.
    Maina-Nock, T.
    Kaloudi, A.
    Giarika, A.
    Lymperis, E.
    Singh, A.
    Kulkarni, H. R.
    Klette, I.
    Krenning, E. P.
    de Jong, M.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S49 - S49
  • [6] Preclinical imaging and radiotherapy of prostate cancer using the theranostic twins(68Ga/177Lu)-radiolabeled peptides
    Lim, J. C.
    Cho, E. H.
    Lee, S. Y.
    Dho, S. H.
    Kim, S. Y.
    Jung, S. H.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S67 - S68
  • [7] Novel developed HPLC analyses of [68Ga]Ga/[177Lu]Lu-EDTMP and [68Ga]Ga/[177Lu]Lu-DOTA-Zoledronate
    Eryilmaz, Kurtulus
    Bakar, Hasan Ensar
    Kilbas, Benan
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2022, 65 (07): : 178 - 186
  • [8] Theranostic Agent Targeting Bone Metastasis: A Novel [68Ga]Ga/[177Lu]Lu-DOTA-HBED-bisphosphonate
    Jin, Wenbin
    Zhao, Ruiyue
    Wang, Ran
    Choi, Seok Rye
    Ploessl, Karl
    Alexoff, David
    Wu, Zehui
    Zhu, Lin
    Kung, Hank F.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (06) : 4793 - 4803
  • [9] Efficacy and Toxicity of 177Lu-NeoBOMB1 for prostate cancer treatment - a preclinical study
    Dalm, S. U.
    de Blois, E.
    Haeck, J.
    Doeswijk, G. N.
    Orlandi, F.
    Barbato, D.
    Tedesco, M.
    Konijnenberg, M.
    de Jong, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S29 - S29
  • [10] [68Ga]NeoBomb1, a new potent GRPR-antagonist for PET imaging - Preclinical and first clinical evaluation in prostate cancer
    Nock, Berthold
    Kaloudi, Aikaterini
    Lymperis, Emmanouil
    Giarika, Athina
    Bergsma, Hendrik
    Mueller, Dirk
    Krenning, Eric
    de Jong, Marion
    Maina, Theodosia
    Baum, Richard
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
12345